New website on EU-China cooperation in Personalised Medicine

The Sino-EU PerMed project (Widening Sino-EU Policy and Research Cooperation in Personalised Medicine) fosters the cooperation between Europe and China in Personalised Medicine. Today, the project  presents its brand new website. It will provide interested parties with information about the project and links to additional EU activities in the field of personalised medicine.

screenshot website


Sino-EU PerMed started in January 2020 thanks to the expertise and commitment of 6 international partners. The consortium received a 2 million euros grant from the European Framework Programme Horizon 2020. The project aims to foster the cooperation between Europe and China in Personalised Medicine in collaboration with the project partner in the next four years.

The partnership comprises 6 excellent research and research management entities, 4 from Europe (Germany, Denmark, Italy and Ireland) and 2 from China: DLR-PT - the Project Management Agency of German Aerospace Center (DLR), Fondazione Toscana Life Sciences, Innovation Fund Denmark, Health Research Board, Jiangsu International Technology Transfer Center and Guangzhou Institute of Biomedicine and Health CAS. Together the project will span the whole healthcare value chain from government organisation to research and technology transfer.

The European partners are actively involved in the EU-funded International Consortium for Personalised Medicine (ICPerMed) as well as related initiatives and activities. Therefore, one of the objectives of this project is also to foster collaboration between Chinese health organisations and ICPerMed, and to identify areas of mutual interest.

The Sino-EU PerMed activities will be coordinated by DLR-PT. The first project phase will focus on scientific, technological and policy mapping in the field of Personalised Medicine with the aim of highlighting collaborations already in place between the EU and China and to identify Personalised Medicine stakeholders in China. In the second phase an EU-China collaboration plan will be developed to reinforce the innovation capacity of the two regions and to establish a permanent dialogue between ICPerMed and the Chinese stakeholders. In the third and last phase, multilevel collaborations will be promoted on academic and industrial level through the organisation of events.

'The Sino-EU PerMed project will significantly support the collaboration between Europe and China in personalised medicine by achieving a trustful and fruitful cooperation and by expanding the network of ICPerMed', states project coordinator Dr. Xiaomeng Shen from DLR-PT.

For more on the Sino-EU PerMed project please follow the link to the brand new Sino-EU PerMed website